Efficient testing of the biomarker positive and negative subgroups in a biomarker-stratified trial
Biometrics · 27.03.2024 · 80 (2)
DOI: 10.1093/biomtc/ujae056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, online erschienen am 11.06.2024. Verfasst von Lang Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7420, USA. Hauptthemen laut MEDLINE: Biomarkers, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
In many randomized placebo-controlled trials with a biomarker defined subgroup, it is believed that this subgroup has the same or higher treatment effect compared with its complement. These subgroups are often referred to as the biomarker positive and negative subgroups. Most biomarker-stratified pivotal trials are aimed at demonstrating a significant treatment effect either in the biomarker positive subgroup or in the overall population. A major shortcoming of this approach is that the treatment can be declared effective in the overall population even though it has no effect in the biomarker negative subgroup. We use the isotonic assumption about the treatment effects in the two subgroups to construct an efficient way to test for a treatment effect in both the biomarker positive and negative subgroups. A substantial reduction in the required sample size for such a trial compared with existing methods makes evaluating the treatment effect in both the biomarker positive and negative subgroups feasible in pivotal trials especially when the prevalence of the biomarker positive subgroup is less than 0.5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7420, USA.
ORCID-Profile: Lang Li, Anastasia Ivanova
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Li, L., & Ivanova, A. (2024). Efficient testing of the biomarker positive and negative subgroups in a biomarker-stratified trial. Biometrics, 80(2). https://doi.org/10.1093/biomtc/ujae056
Vancouver
Li L, Ivanova A. Efficient testing of the biomarker positive and negative subgroups in a biomarker-stratified trial. Biometrics. 2024;80(2). doi:10.1093/biomtc/ujae056
BibTeX
@article{Li2024,
author = {Li, Lang and Ivanova, Anastasia},
title = {Efficient testing of the biomarker positive and negative subgroups in a biomarker-stratified trial},
journal = {Biometrics},
year = {2024},
volume = {80},
number = {2},
doi = {10.1093/biomtc/ujae056}
}
EUVIMED